IAM
BNTC icon

Infinitum Asset Management’s Benitec Biopharma BNTC Stock Holding History

Infinitum Asset Management’s Portfolio BNTC Stock Details BNTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.3M Hold
923,006
– – 1.26% 13
2026
Q1 		$9.83M Buy
923,006
+24,135
+3% +$279K 1.23% 15
2025
Q4 		$12.1M Buy
898,871
+398,871
+80% +$5.52M 1.79% 12
2025
Q3 		$7.01M Hold
500,000
– – 1.29% 16
2025
Q2 		$5.85M Sell
500,000
-625,000
-56% -$8.74M 1.3% 20
2025
Q1 		$18.9M Buy
1,125,000
+915,000
+436% +$11.1M 6.05% 5
2024
Q4 		$2.65M Buy
+210,000
New +$2.27M 1.4% 14

Other funds holding BNTC

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Infinitum Asset Management's BNTC Position: Q2 2026 in Review

Infinitum Asset Management held its Benitec Biopharma (BNTC) position steady in Q2 2026 at 923,006 shares worth $12.3M. The position accounts for 1.26% of the portfolio, ranked #13.

Infinitum Asset Management first reported a position in BNTC in Q4 2024 and has held it in 7 quarters since. The position peaked at $18.9M in Q1 2025. 87 funds tracked by Wall St. Rank hold BNTC as of Q2 2026.

  • Infinitum Asset Management held 923,006 shares of Benitec Biopharma worth $12.3M as of Q2 2026.
  • Infinitum Asset Management left its Benitec Biopharma share count unchanged in Q2 2026.
  • Benitec Biopharma made up 1.26% of Infinitum Asset Management's portfolio in Q2 2026, its #13 holding.
  • Infinitum Asset Management first reported a position in Benitec Biopharma in Q4 2024 and has held it in 7 quarters since.
  • Infinitum Asset Management's Benitec Biopharma position peaked at $18.9M in Q1 2025.
  • 87 funds tracked by Wall St. Rank held Benitec Biopharma as of Q2 2026.

Based on Infinitum Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.